CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice
News

RAPS Launches Global Compensation Survey of Regulatory Professionals

APS has launched its biennial survey of healthcare product regulatory professionals around the world, the Global Compensation & Scope of Practice Survey. It is ...
Continue Reading →
News

Pertinax Pharma further expands into global woundcare markets with appointment of Business Developmemt Manager

Paul Williams brings established international sales expertise to the company’s commercial growth strategy Pertinax Pharma announces that Paul Williams has been...
Continue Reading →
The Rise of Cellular Immunotherapy and Global IP Strategies
Volume 9 Issue 4

The Rise of Cellular Immunotherapy and Global IP Strategies

We are at the beginning of a new age in cancer therapy. With a large and growing number of patents and applications in this space, we can expect a large amount of pa...
Continue Reading →
Needle-free Injection – Eradicating Diseases to Improve Global Health
Volume 9 Issue 4

Needle-free Injection – Eradicating Diseases to Improve Global Health

Needle-free injection technology has evolved significantly over the last 50 years and is now accepted in many routine immunisation settings as a safe and effective v...
Continue Reading →
News

Boehringer Ingelheim signs global license agreement with inmation Software

Boehringer Ingelheim, one of the world‘s leading research-driven pharmaceutical companies, has signed a global license agreement to use the “enterprise:inmation” ind...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026